Drugs / Artemisinin / Artesunate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04387240 | Jan → Sep 2022 | COVID-19 | Princess Nourah Bint Abdulrahman University | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Artemisinin / Artesunate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04387240 ↗ |